Jaguar Health JAGX
NASDAQ JAGX
$0.87 -0.01 (-0.69%)
At close: Aug 21, 2026 · 4:00 PM EDT

Jaguar Health (JAGX) Preferred Dividend Payments (2014 - 2026)

Jaguar Health (JAGX) posted quarterly Preferred Dividend Payments of $6.1 million for Q1 2026, up 264.14% quarter-over-quarter from $1.7 million in Q4 2020.

Jaguar Health (JAGX) Preferred Dividend Payments (2014 - 2026) Analysis & Trends

Jaguar Health (JAGX) has reported Preferred Dividend Payments for 6 consecutive years, with $6.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Preferred Dividend Payments changed N/A year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at $8.1 million (up 181.43% YoY), while the FY2025 annual figure was $141000.0, changed N/A from the prior year.
  • Preferred Dividend Payments advanced to $6.1 million in Q1 2026 per JAGX's latest filing, from $1.7 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $6.1 million in Q1 2026 and bottomed at $6.1 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Jaguar Health 447,549.24 -9.62 Mn 19.11 Mn 6.06 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.06 Mn
Dec 31, 2020 1.67 Mn
Sep 30, 2020 349,000.00
Jun 30, 2020 856,000.00
Mar 31, 2020 480,000.00
Dec 31, 2019 3.99 Mn
Sep 30, 2019 252,000.00
Mar 31, 2019 995,000.00
Sep 30, 2018 1.99 Mn
Jun 30, 2018 -995,000.00
Mar 31, 2018 995,000.00
Jun 30, 2015 159,288.00
Mar 31, 2015 187,086.00
Dec 31, 2014 180,832.00
Sep 30, 2014 180,832.00
Jun 30, 2014 205,163.00
Mar 31, 2014 79,846.00